Last reviewed · How we verify
NCT05431738: ANTIMIG
Anti-Migration System for Anti-reflux Oeso-gastric Stent (ANTIMIG)
NA trial testing Gastroesophageal stent placement in Stent Migration in 180 participants. Currently enrolling.
1 September 2025
Quick facts
| Lead sponsor | Société Française d'Endoscopie Digestive |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 180 |
| Start date | 1 September 2022 |
| Primary completion | 1 September 2025 |
| Estimated completion | 1 September 2025 |
| Sites | 1 location across France |
Drugs / interventions tested
- Gastroesophageal stent placement
Conditions studied
- Stent Migration — all drugs for Stent Migration →
- GastroEsophageal Cancer — all drugs for GastroEsophageal Cancer →
Sponsor
Société Française d'Endoscopie Digestive — full company profile →
Who can join
Adults 18 to 91, any sex, with Stent Migration or GastroEsophageal Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this prospective, controlled, randomized, multicentre, single-blind study is to compare the rate of intragastric migration of 2 types of esophageal stents with and without an anti-migration device placed for locally advanced or metastatic malignant stenosis of the gastroesophageal junction.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05431738
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Stent Migration
Currently open trials in the same condition.
- NCT06666751 — Anterior Segment Optical Coherence Tomography Microstent Positioning · active not recruiting
Other Société Française d'Endoscopie Digestive trials
Trials by the same sponsor.
- NCT07343869 — Multicenter Prospective Cohort on Esophageal Endoscopic Submucosal Dissection · not yet recruiting
- NCT06594718 — Endoscopic Treatment of Zenker's Diverticulum (ZENKTUN) · not yet recruiting
- NCT06535490 — Antibiotic Prophylaxis for EUS-FNA of Pancreatic Cystic Lesions · not yet recruiting
- NCT04251013 — Multicenter RCT for BIliary Brushing: RX Cytology, BOSTON vs. Infinity®, US Endoscopy · NA · completed
- NCT04112563 — COmparison of White Light and Linked COlor Imaging for Detection of RIght COlon Polyps · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05431738 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Société Française d'Endoscopie Digestive
- Last refreshed: 30 July 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05431738.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing